General discussion, page-20231

I like your optimism but let’s not be delusional here. Yes that drug has side effects and yes it’s an injection, but so are drugs for diabetes type 1 and 2.

Lilly is one of the biggest phamas in the world and this drug is definitely a indirect competitor of ours. I can’t see how you can say it isn’t when it treats sleep apnoea and has been approved by the FDA. Lilly is trying to get this drug approved to treat severe sleep apnoea so it will directly compete with us. They are also designing an “at home” product where you can do the injections yourself like diabetes which will be cheaper

no shock why IHL is valued less than $30m and is deemed a penny dreadful by US investors. Open your eyes mate.

https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-reduced-obstructive-sleep-apnea-osa-severity